Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

241

currently held

Exits tracked

163

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-10-07

BP Technology VenturesadminDirector Departure · Resignation of MORELAND, Jennifer Lynne (director) · director resigned · governance change5 days ago

BP Technology Ventures5 days ago

Director Departure · Resignation of MORELAND, Jennifer Lynne (director) · director resigned · governance change

admin

B.P. Marsh & PartnerscapitalCapital Event · capital-return-purchase-own-shares-treasury-capital-date · Capital structure change5 days ago

B.P. Marsh & Partners5 days ago

Capital Event · capital-return-purchase-own-shares-treasury-capital-date · Capital structure change

capital

Arkea CapitaladminBoard change · Management board member change:: TRIDEAU Thomas, Jérôme · Change in the management board6 days ago

Arkea Capital6 days ago

Board change · Management board member change:: TRIDEAU Thomas, Jérôme · Change in the management board

admin

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change6 days ago

Caledonia Investments6 days ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Cervinvest CapitaladminCEO change · Appointment of CEO De Jongh, Guillaume · New CEO appointed1 week ago

Cervinvest Capital1 week ago

CEO change · Appointment of CEO De Jongh, Guillaume · New CEO appointed

admin

Cervinvest CapitaladminChairman change · Appointment of Chairman Radix, Maxence. Departure of CEO Rouland, Antoine · New Chairman appointed. CEO departure · leadership transition underway1 week ago

Cervinvest Capital1 week ago

Chairman change · Appointment of Chairman Radix, Maxence. Departure of CEO Rouland, Antoine · New Chairman appointed. CEO departure · leadership transition underway

admin

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Delpharm4 periods IDIA Small & Midcap	Pharma	France	Idia	2007	5yr	Active	–	–
Genetic3 periods Fondo Italiano Private Equity Co-Investimenti (FIPEC)	Pharma	Italy	Fondo Italiano d'Investimento SGR	2025	1yr	Active	–	–
Medincell3 periods Crédit Mutuel Equity	Pharma	France	Crédit Mutuel Equity	2017	9yr	Active	–	–
Kent Pharmaceuticals2 periods DS Cornerstone Fund	Pharma	UK	Duke Street	2019	7yr	Active	–	–
Marcyrl2 periods Amethis Fund III	Pharma	Egypt	Edmond de Rothschild Private Equity (France)	2023	3yr	Active	–	–
Opella2 periods Bpifrance	Pharma	–	Bpifrance Investissement	2025	1yr	Active	–	–
PharOS2 periods Viessmann Generations Group Balance Sheet	Pharma	Greece	Viessmann Generations Group	2024	2yr	Active	–	–
Sagitta Pharma2 periods Acto V	Pharma	France	Andera Partners	2021	5yr	Active	–	–
Theramex2 periods PAI Europe VII	Pharma	United Kingdom	PAI Partners	2022	4yr	Active	–	–
Abarceo Pharma Almi Invest (Regional funds)	Pharma	Sweden	Almi Invest	2021	5yr	Active	–	–
Advanz Pharma Nordic Capital Fund X	Pharma	United Kingdom	Nordic Capital	2021	5yr	Active	–	–
Akinion Pharmaceuticals Rosetta Capital IV	Pharma	Sweden	Rosetta Capital	2013	13yr	Active	–	–
Alcala Farma Latin American Private Equity Fund VII	Pharma	Spain	Advent International	–	–	Active	–	–
almapharm Armira Evergreen	Pharma	Germany	Armira	2024	2yr	Active	–	–
Aphaia Pharma Bioventure Club Deals	Pharma	Switzerland	Bioventure Management	2018	8yr	Active	–	–
Artroa AB SLU Holding	Pharma	Sweden	SLU Holding	2023	3yr	Active	–	–
Atec Pharmatechnik GmbH GBK Evergreen Holdings	Pharma	Germany	GBK Beteiligungen AG	2022	4yr	Active	–	–
Avia Pharma Impilo Investment Pool 2	Pharma	Sweden	Impilo	2024	2yr	Active	–	–
Basic Pharma SHS VI	Pharma	Netherlands	SHS Gesellschaft für Beteiligungsmanagement	2026	0yr	Active	–	–
Biofarma Group Ardian Buyout Fund VII	Pharma	Italy	Ardian	2022	4yr	Active	–	–
Bohus Biotech Flerie Invest	Pharma	Sweden	Flerie	2022	4yr	Active	–	–
Catalent Novo Holdings Principal Investments	Pharma	United States	Novo Holdings	2024	2yr	Active	–	–
Ceva II IXO 5	Pharma	France	iXO Private Equity	2025	1yr	Active	–	–
Clinigen Triton Fund V	Pharma	Germany	Triton Partners	2022	4yr	Active	–	–
Cooperation Pharmaceutique CM-CIC Debt Fund 3	Pharma	France	CIC Private Debt	2021	5yr	Active	–	–
cormeo Bertelsmann Digital Media Investments (BDMI)	Pharma	Germany	Bertelsmann Investments	2025	1yr	Active	–	–
Crossject Vatel Flexible	Pharma	France	VATEL CAPITAL	2025	1yr	Active	–	–
Dechra Pharmaceuticals EQT X	Pharma	United Kingdom	EQT	2024	2yr	Active	–	–
EMAS Pharma Kester Capital III	Pharma	UK	Kester Capital	2024	2yr	Active	–	–
Euro Vital Pharma Apera Private Debt Fund II	Pharma	Germany	Apera Asset Management	2021	5yr	Active	–	–
Fada Pharma Latin American Private Equity Fund VII	Pharma	Latin America	Advent International	–	–	Active	–	–
Frontier Biosolutions Flerie Invest	Pharma	Germany	Flerie	2023	3yr	Active	–	–
FrostPharma Priveq Investment VI	Pharma	Sweden	Priveq	2023	3yr	Active	–	–
GPW Holding Silver Investment Partners	Pharma	Germany	Silver Investment Partners	2020	6yr	Active	–	–
Grupo Biotoscana Latin American Private Equity Fund VII	Pharma	Latin America	Advent International	–	–	Active	–	–
Haihe Pharmaceutical Warburg Pincus Other Investments	Pharma	China	Warburg Pincus	–	–	Active	–	–
Immedica Impilo Investment Pool 1	Pharma	Sweden	Impilo	2018	8yr	Active	–	–
InfoRLife BC Partners XII	Pharma	Switzerland	BC Partners	2026	0yr	Active	–	–
Jubilant Life Sciences General Atlantic	Pharma	India	General Atlantic	–	–	Active	–	–
KalVista Pharmaceuticals Novo Holdings Principal Investments	Pharma	United States	Novo Holdings	2025	1yr	Active	–	–
Laboratorio LKM Latin American Private Equity Fund VII	Pharma	Mexico	Advent International	–	–	Active	–	–
Laboratorios Ovejero ADE Capital Sodical	Pharma	Spain	Sodical	2018	8yr	Active	–	–
Labormed Latin American Private Equity Fund VII	Pharma	Romania	Advent International	–	–	Active	–	–
LEO Pharma Nordic Capital Fund X	Pharma	Denmark	Nordic Capital	2021	5yr	Active	–	–
Medison Vitruvian Investment Partnership IV	Pharma	Israel	Vitruvian Partners	2022	4yr	Active	–	–
Medovia Novax	Pharma	Sweden	Novax	2015	11yr	Active	–	–
Mirum Pharmaceuticals Novo Holdings Growth Investments	Pharma	United States	Novo Holdings	2018	8yr	Active	–	–
Montplet Corpfin Capital Fund VI	Pharma	Spain	Corpfin Capital	2025	1yr	Active	–	–
MyCural Therapeutics AB SLU Holding	Pharma	Sweden	SLU Holding	2022	4yr	Active	–	–
NorthX Biologics Flerie Invest	Pharma	Sweden	Flerie	2021	5yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.